Roland Grenningloh
About Roland Grenningloh
Roland Grenningloh is the Executive Director of Integrative Sciences - Immunology at Bristol Myers Squibb, with extensive experience in immunology and a proven track record in scientific research and drug development.
Company
Roland Grenningloh currently works at Bristol Myers Squibb as the Executive Director of Integrative Sciences in Immunology. He is based in Cambridge, Massachusetts, United States. He leads initiatives in the integrative sciences domain, contributing significantly to the field of immunology.
Title
As the Executive Director of Integrative Sciences - Immunology at Bristol Myers Squibb, Roland Grenningloh oversees the strategic direction and implementation of scientific projects. His role involves guiding research efforts and fostering collaboration across teams focused on immunology.
Education and Expertise
Roland Grenningloh holds a Ph.D. in Immunology from GBF, Centre for Biotechnological Research and the University of Braunschweig, where he studied from 1994 to 1998. He also has an MS in Immunology and Biology from the University of Münster, completed in 1994 after six years. His areas of expertise include rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis (MS), inflammatory bowel disease (IBD), fibrosis, and infectious disease.
Background
Roland Grenningloh has a comprehensive background in immunology and pharmacology. He has held several key positions, including Senior Director of Immunology/Neurology and Director of Preclinical Pharmacology at EMD Serono, Inc. His experience also includes roles at Merck Serono and Brigham and Women's Hospital, Harvard Medical School. He has consistently contributed to drug discovery and clinical introduction of both small and large molecules.
Scientific Achievements
Roland Grenningloh has a proven track record of scientific achievements, including publications, patents, and Investigational New Drug (IND) filings. He regularly presents his scientific findings to internal review boards, health authorities, and key opinion leader panels. His work encompasses significant contributions to the understanding and treatment of various chronic diseases, demonstrated through a robust list of scientific contributions and presentations.